[1]Mao D , Li J , Liu S , et al. Prevalence and risk factors of atopic dermatitis in Chinese adults: a nationwide population-based cross-sectional study[J]. Chin Med J (Engl), 2023, 136(5):604-606.[2]Murota H , Koike Y , Morisaki H , et al. Exacerbating factors and disease burden in patients with atopic dermatitis[J]. Allergol Int, 2022, 71(1):25-30.[3]郝飞,张建中. 特应性皮炎的研究现状与展望[J]. 中华医学杂志,2023,103(32):2465-2469.[4]Chovatiya R, Paller AS. JAK inhibitors in the treatment of atopic dermatitis. J Allergy Clin Immunol. 2021 Oct;148(4):927-940.[5]王婷琳,沈佚葳,周城,等.中国六城市AA患病率调查[J].中华皮肤科杂志,2009,42(10):668-670.[6]中华医学会皮肤性病学分会毛发学组.中国AA诊疗指南(2019)[J].临床皮肤科杂志, 2020(002):69-72.[7]李明,周俐宏,李邻峰. Janus激酶抑制剂在皮肤病治疗中的应用前景[J]. 中华皮肤科杂志,2020,53(10):845-848.